A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page

Research Programs

Frontiers in Oncology Seminars

2012 - 2013 Frontiers in Oncology Seminars

The Frontiers in Oncology lecture series brings outstanding investigators involved in cancer research to the UMGCC campus each month. The series is designed to educate and provide exposure to the latest developments in cancer biology, treatment and diagnosis. It will be of interest to faculty members, oncologists, medical interns, nurses, pharmacologists, and research fellows.

When: 3rd Wednesday of every month, 8:00 a.m.
Where:

University of Maryland Health Science Facility II (HSF II) Auditorium
20 S. Penn Street, Baltimore, MD 21201

CME Credit: One (1)
Register online.
Contact:

410-328-7516
Note: If you would like to meet with the speaker, please contact Florence Wade.

2012-2013 Seminar Schedule
From left:  Dr. Kevin Cullen, Dr. Jacob M. Rowe and Dr. Aaron Rapoport (sponsor)

September 12, 2012

Jacob M. Rowe M.D.
Director, Department of Hematology
Shaare Zedek Medical Center
Jerusalem

Interpreting Outcome Data on Transplantation for Adults with Acute Lymphoblastic Leukemia

From left to right:  Gordon Mills, M.D., Ph.D.; Angela H. Brodie, Ph.D. (sponsor)

October 17, 2012

Gordon Mills, M.D., Ph.D.
University of Texas, MD Anderson Cancer Center
Division of Cancer Medicine
1515 Holcombe Blvd., Box 950
Houston, TX 77030

Functional Genomics: Drugging the Cancer Genome

From left: Dr. A. Thomas Look, Dr. Curt Civin (sponsor)

November 14, 2012

A. Thomas Look, M.D.
Vice Chair for Research
Department of Hematology/Oncology
Dana Farber Cancer Institute
Boston, MA 02115

Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine Activation of MET, Providing a Novel Therapeutic Target in Acute Myeloid Leukemia

December 19, 2012 -- CANCELLED

Peter Sicinski, M.D., Ph.D.
Professor of Pathology
Harvard Medical School
Dana Farber Cancer Institute
450 Brookline Avenue; Smith 922A
Boston, M 02115

From left: Dr. Angela Brodie (sponsor), Dr. Carlos Arteaga, and Dr. Kevin Cullen

January 16, 2013

Carlos L. Arteaga, M.D.
Professor of Medicine and Cancer Biology
Division of Oncology/VUMC
2220 Pierce Avenue, 777 PRB
Nashville, TN 37232-6307

Neoadjuvant Trials in Breast Cancer: Role in Clinical Development and Discovery of Mechanisms of Drug Resistance

February 20, 2013

Warren S. Pear, M.D., Ph.D.
Department of Pathology
Abramson Family Cancer Research Institute
Perelman School of Medicine
University of Pennsylvania

Notch at the Interface of Leukemic Transformation and Lymphocyte Development

From left: Dr. Douglas Lowy, Dr. Kevin Cullen (sponsor)

March 20, 2013

Douglas R. Lowy, M.D.
NIH/NCI
Head, Signaling and Oncogenesis Section
Laboratory Chief
Bethesda, MD 20892

Toward the Prevention of HPV-Associated Cancer by HPV Vaccination

From left:  Dr. Kevin Cullen, Dr. Jean-Pierre Issa, Dr. Feyruz Rassool

April 17, 2013

Jean-Pierre Issa, M.D.
Professor of Medicine
Director, Fels Institute for Cancer and Molecular Biology
Temple University
Philadelphia, PA 19140

Epigenetic Reprogramming as Cancer Therapy

From left:  Dr. Kevin Cullen, Dr. Douglas Ross (sponsor), Dr. Steve Akman, and Dr. Nicholas Bachur.

May 15, 2013

Steven A. Akman, M.D., Ph.D.
Professor , Hematology and Oncology
Wake Forest School of Medicine
Medical Center Blvd.
Winston-Salem, NC 27157

The Role of DNA/RNA Helicase DHX36 in Hematopoietic Development

From left: Dr. Ronald Gartenhaus (sponsor), Dr. Jonathan Licht and Dr. Kevin Cullen

June 19, 2013

Jonathan D. Licht, M.D.
Professor and Chief
James B. Drew, MS, MBA, Division Administrator
Division of Hematology/Oncology
Northwestern University
Chicago, IL 60601

Disorders of Histone Methylation in Hematological Malignancy



This page was last updated on: August 27, 2013.